F. Guelfucci

First name
F.
Last name
Guelfucci
Wade, A. G., Saragoussi, D., Despiegel, N., Francois, C., Guelfucci, F., & Toumi, M. (2010). Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK. Curr Med Res Opin. http://doi.org/10.1185/03007991003738519
Chapple, C. R., Nazir, J., Hakimi, Z., Bowditch, S., Fatoye, F., Guelfucci, F., et al. (2017). Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice. Eur Urol. http://doi.org/10.1016/j.eururo.2017.01.037
Gayle, A., Tebboth, A., Pang, M., Guelfucci, F., Argoubi, R., Sherman, S., & Mak, V. (2019). Real-life prescribing of asthmatic treatments in UK general practice over time using 2014 BTS/SIGN steps. NPJ Prim Care Respir Med. http://doi.org/10.1038/s41533-019-0137-7
Chin, R. F. M., Pickrell, W. O., Guelfucci, F., Martin, M., & Holland, R. (2021). Prevalence, healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage cohort study. Seizure. http://doi.org/10.1016/j.seizure.2021.05.025
Bianic, F., Guelfucci, F., Robin, L., Martre, C., Game, D., & Bockenhauer, D. (2021). Epidemiology of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data. Nephron. http://doi.org/10.1159/000516876